Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Clonal and Single Cell Dynamics of Resistance to Graft-Versus-Leukemia (GvL) in Chronic Lymphocytic Leukemia (CLL)

Pavan Bachireddy, MD, Nikolaos Barkas, PhD, Sachet A Shukla, PhD, Samuel Freeman, Liudmila Elagina, PhD, Vinhkhang N Nguyen, Kendell Clement, PhD, Ignaty Leshchiner, PhD, Jennifer R. Brown, MD PhD, Donna S Neuberg, ScD, Vincent T. Ho, MD, Robert J. Soiffer, MD, Jerome Ritz, MD PhD, Gad Getz, PhD, Edwin P. Alyea, III, MD, Peter Kharchenko, PhD, Catherine J. Wu, MD

Blood (2018) 132 (Supplement 1): 820.

https://doi.org/10.1182/blood-2018-99-116681

Published: 2018

Journal Articles

Multiple Myeloma Cross-Presents Neutrophil Elastase and Proteinase 3 and Becomes Susceptible to PR1-Targeting Immunotherapy

Gheath Alatrash, DO, PhD, Pariya Sukhumalchandra, BS, Mao Zhang, MPH, Anna Sergeeva, PhD, Haroon Jakher, BS, Jinsheng Weng, Ph.D, Lisa S St. John, PhD, Kathryn Ruisaard, BS, Karen Clise-Dwyer, PhD, Sijie Lu, PhD, Jeffrey J. Molldrem, MD

Blood (2012) 120 (21): 4973.

https://doi.org/10.1182/blood.V120.21.4973.4973

Published: 2012

Journal Articles

Efficient Generation of HLA-A24-Restricted WT1-Specific Cytotoxic T Lymphocytes Using Gene-Engineered Artificial Antigen-Presenting Cells

Masahiro Ogasawara, MD, Ph.D, Tomohiro Yamakawa, MD, Yuki Katsura, MD, Kanako Shima, MD, Toshihiro Matsukawa, MD, Minoru Kanaya, MD, Koichiro Minauchi, MD, Masanobu Nakata, MD, Shuichi Ota, MD, PhD, Kiyotoshi Imai, MD, Ph.D, Teiichi Hirano, MD, Ph.D, Naoki Kobayashi, MD, Ph.D, Yoshio Kiyama, MD, Naoto Hirano, MD, Ph.D

Blood (2010) 116 (21): 2101.

https://doi.org/10.1182/blood.V116.21.2101.2101

Published: 2010

Journal Articles

Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology

Sophia S. Wang, Amr M. Abdou, Lindsay M. Morton, Rasmi Thomas, James R. Cerhan, Xiaojiang Gao, Wendy Cozen, Nathaniel Rothman, Scott Davis, Richard K. Severson, Leslie Bernstein, Patricia Hartge, Mary Carrington

Blood (2010) 115 (23): 4820–4823.

https://doi.org/10.1182/blood-2010-01-266775

Published: 2010

Includes: Supplemental data

Journal Articles

Anti CMV Immunotherapy with Donor Antigen Specific Lymphocytes Selected with GMP HLA Class 1 Tetramer Reagents.

Liliane Dal Cortivo, Mathilde Bahuaud, Marie Noelle Lacassagne, Vincent Monchois, Cecile Ducasse, Marina Cavazzana-Calvo

Blood (2009) 114 (22): 4492.

https://doi.org/10.1182/blood.V114.22.4492.4492

Published: 2009

Journal Articles

Upregulation of HLA-G Gene Expression in Malignant Hematopoietic Cells Treated with 5-Aza-2′- Ddeoxycytidine.

Firas Alsabty, Martin Mistrik, MD, PhD, Katarina Polakova

Blood (2009) 114 (22): 4567.

https://doi.org/10.1182/blood.V114.22.4567.4567

Published: 2009

Journal Articles

Myeloid Leukemic Blasts Use the Endogenous HLA Class I Antigen Processing Machinery for Peptide Loading Onto HLA Class II Molecules: Implications for Immunotherapy.

Marvin M. van Luijn, Martine E.D. Chamuleau, MD, PhD, Maaike E. Ressing, PhD, Emmanuel J.H.J. Wiertz, PhD, Suzanne Ostrand-Rosenberg, PhD, Yuri Souwer, Adri Zevenbergen, Gert J. Ossenkoppele, MD, PhD, Arjan A. van de Loosdrecht, MD, PhD, S. Marieke van Ham, PhD

Blood (2009) 114 (22): 3114.

https://doi.org/10.1182/blood.V114.22.3114.3114

Published: 2009

Journal Articles

Novel Monoclonal Antibody Enhances Natural Killer (NK) Cell Cytotoxicity against Multiple Myeloma (MM): Interim Phase 1 Trial Results.

Don Benson, MD, PhD, Craig C. Hofmeister, MD, Swaminathan Padmanabhan, MD, MBBS, Rafat Abonour, Attaya Suvannasankha, MD, Alain Mita, Patrick Squiban, MD, Megan K Smith, MS, CNP, RN, Courtney E Bakan, Marc Marzetto, Pascale Andre, PhD, Jerome Tollier, Michael A. Caligiuri, M.D., Sherif Farag, MBBS, PhD

Blood (2009) 114 (22): 2880.

https://doi.org/10.1182/blood.V114.22.2880.2880

Published: 2009

Journal Articles

Single Agent Gemtuzumab Ozogamicin (Mylotarg) Can Induce Hematologic Remissions in Patients with Refractory Acute Myelogenous Leukemia (AML) Relapse Following Allogeneic Stem Cell Transplantation but May Precipitate Acute Graft-Versus-Host Disease (GVHD).

Mounzer E. Agha, MD, Anastasios Raptis, MD, Sarah B. Miller, Michelle Taylor, Markus Y. Mapara, MD, PhD

Blood (2005) 106 (11): 5405.

https://doi.org/10.1182/blood.V106.11.5405.5405

Published: 2005

Journal Articles

Killer Cell Immunoglobulin-Like Receptor Genotype and HTLV-1 Associated Disease’s Susceptibilities.

Kosuke Obama, Yoshitaka Furukawa, Mitsutoshi Tara, Sara Marshall, Alison Levoguer, Mineki Saito, Charles Bangham, Mitsuhiro Osame

Blood (2005) 106 (11): 4481.

https://doi.org/10.1182/blood.V106.11.4481.4481

Published: 2005

Journal Articles

Analysis of Memory T Lymphocytes Activity Following Stimulation with HLA-A24, A1 and Cw4 Restricted 9- and 10-mer Cytomegalovirus pp65 Overlapping Peptides.

Monica Ghei, David F. Stroncek, MD, Maurizio Provenzano, MD

Blood (2004) 104 (11): 2876.

https://doi.org/10.1182/blood.V104.11.2876.2876

Published: 2004

Journal Articles

Eradication of B-Lymphoma by Allogeneic Anti-Third Party Host Non-Reactive CTLs: Growing Evidence for TCR Independent Reactivity Against B-Cell Malignancies.

Shraga Aviner, MD, Fabian D. Arditti, PhD, Rinat Arbel-Goren, PhD, Tirza Klein, PhD, Yair Reisner, PhD

Blood (2004) 104 (11): 3055.

https://doi.org/10.1182/blood.V104.11.3055.3055

Published: 2004

Journal Articles

A Multi-Institutional Study of Extracorporeal Photoimmune Therapy with UVADEX® for the Prevention of Acute GVHD in Patients Undergoing Standard Myeloablative Conditioning and Allogeneic Hematopoietic Stem Cell Transplantation.

Paul J. Shaughnessy, MD, Brian J. Bolwell, MD, Sunil Abhyankar, MD, Koen van Besien, MD, Martin Mistrik, MD PhD, Andrew Grigg, MBBS, Anthony Dodds, MBBS, H. Miles Prince, MBBS, Alexandra Machado, MD, Ulrich Thienel, MD, PhD, Jim Wang, Francine Foss, MD, Jane Apperley, MBChB

Blood (2004) 104 (11): 1230.

https://doi.org/10.1182/blood.V104.11.1230.1230

Published: 2004

Journal Articles

T Cell Activation by t(9;22) Acute Lymphoblastic Leukemia-Derived Dendritic-Like Cells Is Associated with Increased Expression of Antigen Processing Machinery Components.

Jonathan A. Claus, Michael A. Brady, BS, Jaewoo Lee, PhD, Kathleen A. Donohue, MS, Soldano Ferrone, MD, PhD, Meir Wetzler, MD

Blood (2004) 104 (11): 4301.

https://doi.org/10.1182/blood.V104.11.4301.4301

Published: 2004

Journal Articles

Reduced Risk of Residual Molecular and Hematological Relapse in Patients with Cml after KIRir-Ligand Mismatched Hematpoietic Stem Cell Transplantation.

Ahmet H. Elmaagacli, MD, Hellmut Ottinger, MD, Koldehoff Michael, MD, Peceny Rudolf, MD, Nina K. Steckel, MD, Rudolf Trenschel, MD, Harald Biersack, MD, Hans Grosse-Wilde, MD, Michael Flasshove, MD, Dietrich W. Beelen, MD

Blood (2004) 104 (11): 974.

https://doi.org/10.1182/blood.V104.11.974.974

Published: 2004

Journal Articles

A Defined Donor Activating Natural Killer Cell Receptor Phenotype Protects Against Leukemic Relapse after HLA-Identical Hematopoietic Stem Cell Transplantation.

Christian J. Demanet, MD, PhD, Sonja J. Verheyden, Rik J. Schots, MD, PhD

Blood (2004) 104 (11): 3338.

https://doi.org/10.1182/blood.V104.11.3338.3338

Published: 2004

Journal Articles

Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack?

Christian Demanet, Arend Mulder, Veronique Deneys, Maria J. Worsham, Piet Maes, Frans H. Claas, Soldano Ferrone

Blood (2004) 103 (8): 3122–3130.

https://doi.org/10.1182/blood-2003-07-2500

Published: 2004

Journal Articles

Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain

Giovanni B. Ferrara, Andrea Bacigalupo, Teresa Lamparelli, Edoardo Lanino, Laura Delfino, Anna Morabito, Anna M. Parodi, Cinzia Pera, Sarah Pozzi, Maria P. Sormani, Paolo Bruzzi, Domenico Bordo, Martino Bolognesi, Giuseppe Bandini, Andrea Bontadini, Mario Barbanti, Guido Frumento

Blood (2001) 98 (10): 3150–3155.

https://doi.org/10.1182/blood.V98.10.3150

Published: 2001

Journal Articles

Induction of cytomegalovirus (CMV)–specific T-cell responses using dendritic cells pulsed with CMV antigen: a novel culture system free of live CMV virions

Karl Peggs, Stephanie Verfuerth, Stephen Mackinnon

Blood (2001) 97 (4): 994–1000.

https://doi.org/10.1182/blood.V97.4.994

Published: 2001

NARROW

Clonal and Single Cell Dynamics of Resistance to Graft-Versus-Leukemia (GvL) in Chronic Lymphocytic Leukemia (CLL)

Multiple Myeloma Cross-Presents Neutrophil Elastase and Proteinase 3 and Becomes Susceptible to PR1-Targeting Immunotherapy

Efficient Generation of HLA-A24-Restricted WT1-Specific Cytotoxic T Lymphocytes Using Gene-Engineered Artificial Antigen-Presenting Cells

Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology

Anti CMV Immunotherapy with Donor Antigen Specific Lymphocytes Selected with GMP HLA Class 1 Tetramer Reagents.

Upregulation of HLA-G Gene Expression in Malignant Hematopoietic Cells Treated with 5-Aza-2′- Ddeoxycytidine.

Myeloid Leukemic Blasts Use the Endogenous HLA Class I Antigen Processing Machinery for Peptide Loading Onto HLA Class II Molecules: Implications for Immunotherapy.

Novel Monoclonal Antibody Enhances Natural Killer (NK) Cell Cytotoxicity against Multiple Myeloma (MM): Interim Phase 1 Trial Results.

Single Agent Gemtuzumab Ozogamicin (Mylotarg) Can Induce Hematologic Remissions in Patients with Refractory Acute Myelogenous Leukemia (AML) Relapse Following Allogeneic Stem Cell Transplantation but May Precipitate Acute Graft-Versus-Host Disease (GVHD).

Killer Cell Immunoglobulin-Like Receptor Genotype and HTLV-1 Associated Disease’s Susceptibilities.

Analysis of Memory T Lymphocytes Activity Following Stimulation with HLA-A24, A1 and Cw4 Restricted 9- and 10-mer Cytomegalovirus pp65 Overlapping Peptides.

Eradication of B-Lymphoma by Allogeneic Anti-Third Party Host Non-Reactive CTLs: Growing Evidence for TCR Independent Reactivity Against B-Cell Malignancies.

A Multi-Institutional Study of Extracorporeal Photoimmune Therapy with UVADEX® for the Prevention of Acute GVHD in Patients Undergoing Standard Myeloablative Conditioning and Allogeneic Hematopoietic Stem Cell Transplantation.

T Cell Activation by t(9;22) Acute Lymphoblastic Leukemia-Derived Dendritic-Like Cells Is Associated with Increased Expression of Antigen Processing Machinery Components.

Reduced Risk of Residual Molecular and Hematological Relapse in Patients with Cml after KIRir-Ligand Mismatched Hematpoietic Stem Cell Transplantation.

A Defined Donor Activating Natural Killer Cell Receptor Phenotype Protects Against Leukemic Relapse after HLA-Identical Hematopoietic Stem Cell Transplantation.

Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack?

Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain

Induction of cytomegalovirus (CMV)–specific T-cell responses using dendritic cells pulsed with CMV antigen: a novel culture system free of live CMV virions

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only